Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...

Scientists at Oxford University and drugmaker GSK to ‘detect the undetectable’ and identify changes in cells that start up to ...

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

Scientists at Oxford University, which pioneered Covid-19 vaccines, turn attention to ‘detecting the undetectable’ and ...

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...

GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...

Professor Sarah Blagden, from the University of Oxford, will co-lead the new GSK-Oxford Cancer Immuno-Prevention Programme, which is backed by £50 million from GSK. She told BBC Radio 4’s Today ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines. The University of Oxford and GSK are to work on a vaccine to target cells in the ...